News and Trends 2 May 2016
Galapagos and AbbVie expand their Cystic Fibrosis collaboration
Galapagos and AbbVie expand their ongoing collaboration in Cystic Fibrosis. With a growth in the portfolio, Galapagos’ milestones increase from €300M to €520M. The most famous collaboration between AbbVie (US) and Galapagos (Belgium) was perhaps their candidate for rheumatoid arthritis – which hit a reef in September, knocking Galapagos’ stock by 39%. But the less […]